Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FH471
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,661
Award facts
- Contract value 100% obligated
- $19,660.52 Current and potential, with all options
- Completion date
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $19,660.52 delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 20, 2026, with an ultimate completion date of January 20, 2026. This firm fixed-price, non-set-aside contract represents a task order issued against a larger Indefinite Delivery Contract (IDC) vehicle. The work will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of parent company Cencora, Inc., a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems.
This delivery order falls under the Defense Logistics Agency Troop Support Medical's pharmaceutical prime vendor program, which leverages AmerisourceBergen's comprehensive $999,999,999.00 IDC (valued through December 2026) to supply pharmaceutical products and medical supplies globally. The company's contract portfolio demonstrates expertise in delivering brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military treatment facilities and federal healthcare systems. The non-competitive award status reflects AmerisourceBergen's established position as a qualified vendor under the DLA's pharmaceutical supply chain infrastructure.
Quick answers
Who was awarded contract SPE2DU26FH471?
SPE2DU26FH471 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DU26FH471 worth?
The government has obligated $19,661 on SPE2DU26FH471.
Is contract SPE2DU26FH471 an order under another contract?
Yes. SPE2DU26FH471 is a delivery order under SPE2DU25D4116, an indefinite delivery contract.
Was contract SPE2DU26FH471 competed?
The extent of competition for SPE2DU26FH471 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award